Market Analysis and Insights: Global Companion Diagnostics Market

The global Companion Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Companion Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Companion Diagnostics market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Companion Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Companion Diagnostics market.


Global Companion Diagnostics Scope and Market Size

Companion Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Companion Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

  • Polymerase Chain Reaction (PCR)
  • Immunohistochemistry (IHC)
  • In Situ Hybridization (ISH)
  • Next Generation Sequencing (NGS)

Segment by Application

  • Hospitals
  • Pharmaceutical Companies
  • Laboratories
  • Other

By Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

By Company

  • Roche Holdings
  • Abbott Laboratories
  • Thermo Fisher Scientific
  • Agilent Technologies
  • Life Technologies
  • GE Healthcare
  • Agendia
  • Qiagen
  • Genomic Health
  • Myriad Genetics
  • Advanced Cell Diagnostics
  • Danaher
  • Applied Proteomics

Table of content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Polymerase Chain Reaction (PCR)
1.2.3 Immunohistochemistry (IHC)
1.2.4 In Situ Hybridization (ISH)
1.2.5 Next Generation Sequencing (NGS)
1.3 Market by Application
1.3.1 Global Companion Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Pharmaceutical Companies
1.3.4 Laboratories
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Companion Diagnostics Market Perspective (2016-2027)
2.2 Companion Diagnostics Growth Trends by Regions
2.2.1 Companion Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Companion Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Companion Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Companion Diagnostics Industry Dynamic
2.3.1 Companion Diagnostics Market Trends
2.3.2 Companion Diagnostics Market Drivers
2.3.3 Companion Diagnostics Market Challenges
2.3.4 Companion Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Companion Diagnostics Players by Revenue
3.1.1 Global Top Companion Diagnostics Players by Revenue (2016-2021)

276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170 / +91 8087042414

Follow Us On linkedin :-